ctrl K

Watchlist Price Alert

Tarsus Pharmaceuticals In... (TARS)

NASDAQ: TARS · Real-Time Price · USD

43.94

0.99 (2.31%)

At close: Jun 02, 2025, 3:59 PM

43.95

0.02%

After-hours: Jun 02, 2025, 04:52 PM EDT

Tarsus Pharmaceuticals Revenue Breakdown

Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
License Fees and Collaboration Revenue	2.89M	2.72M	955K	2.08M
License Fees and Collaboration Revenue Growth	+6.48%	+184.61%	-53.98%	n/a
Product Revenue	180.06M	14.73M	n/a	n/a
Product Revenue Growth	+1122.48%	n/a	n/a	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2018	Mar 31, 2018
Selling, General, and Administrative Revenue	85M	69.03M	57.91M	58.79M	51.58M	43.01M	30.32M	20.27M	15.1M	14.63M	11.99M	10.38M	7.95M	6.77M	6.67M	6.79M	5.16M	3.89M	2.15M	1.53M	606K	387K	234K	112.25K	112.25K
Selling, General, and Administrative Revenue Growth	+23.13%	+19.20%	-1.50%	+13.99%	+19.93%	+41.82%	+49.56%	+34.31%	+3.16%	+22.00%	+15.59%	+30.58%	+17.34%	+1.51%	-1.81%	+31.67%	+32.65%	+80.93%	+40.89%	+151.82%	+56.59%	+65.38%	+108.46%	0.00%	n/a
Research and Development Revenue	14.41M	16.87M	12.13M	12.32M	12.07M	13.3M	12.11M	12.55M	12.36M	10.03M	10.91M	9.6M	12.08M	8.04M	10.21M	7.2M	16.26M	7.59M	7.99M	1.74M	1.51M	697K	399K	225.25K	225.25K
Research and Development Revenue Growth	-14.60%	+39.12%	-1.55%	+2.10%	-9.31%	+9.91%	-3.52%	+1.54%	+23.21%	-8.10%	+13.63%	-20.51%	+50.30%	-21.27%	+41.71%	-55.70%	+114.33%	-5.06%	+360.05%	+14.88%	+116.93%	+74.69%	+77.14%	0.00%	n/a